Logo image of CNXT

VANECK CHINEXT ETF (CNXT) Stock Overview

USA - NYSEARCA:CNXT - US92189F6271 - ETF

44.3608 USD
-0.22 (-0.49%)
Last: 10/3/2025, 8:04:03 PM
Fundamental Rating

5

Overall CNXT gets a fundamental rating of 5 out of 10. We evaluated CNXT against 81 industry peers in the Automobile Components industry. Both the profitability and the financial health of CNXT get a neutral evaluation. Nothing too spectacular is happening here. CNXT has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

6

1. Profitability

1.1 Basic Checks

In the past year CNXT was profitable.
In the past year CNXT had a positive cash flow from operations.
Each year in the past 5 years CNXT has been profitable.
Each year in the past 5 years CNXT had a positive operating cash flow.
CNXT Yearly Net Income VS EBIT VS OCF VS FCFCNXT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B 5B

1.2 Ratios

Looking at the Return On Assets, with a value of 4.39%, CNXT is in the better half of the industry, outperforming 62.96% of the companies in the same industry.
CNXT has a Return On Equity of 8.81%. This is in the better half of the industry: CNXT outperforms 60.49% of its industry peers.
CNXT's Return On Invested Capital of 8.17% is in line compared to the rest of the industry. CNXT outperforms 59.26% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for CNXT is in line with the industry average of 8.51%.
Industry RankSector Rank
ROA 4.39%
ROE 8.81%
ROIC 8.17%
ROA(3y)5.45%
ROA(5y)4.73%
ROE(3y)10.95%
ROE(5y)10.02%
ROIC(3y)9.25%
ROIC(5y)8.5%
CNXT Yearly ROA, ROE, ROICCNXT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

CNXT has a better Profit Margin (5.84%) than 65.43% of its industry peers.
CNXT's Profit Margin has been stable in the last couple of years.
Looking at the Operating Margin, with a value of 10.65%, CNXT is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
In the last couple of years the Operating Margin of CNXT has remained more or less at the same level.
CNXT has a Gross Margin of 27.60%. This is comparable to the rest of the industry: CNXT outperforms 59.26% of its industry peers.
CNXT's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 10.65%
PM (TTM) 5.84%
GM 27.6%
OM growth 3Y-2.46%
OM growth 5Y-1.24%
PM growth 3Y-3.58%
PM growth 5Y-0.79%
GM growth 3Y-0.99%
GM growth 5Y-0.59%
CNXT Yearly Profit, Operating, Gross MarginsCNXT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

More info and screens

5

2. Health

2.1 Basic Checks

CNXT has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for CNXT has been reduced compared to 1 year ago.
CNXT has less shares outstanding than it did 5 years ago.
CNXT has a worse debt/assets ratio than last year.
CNXT Yearly Shares OutstandingCNXT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
CNXT Yearly Total Debt VS Total AssetsCNXT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.2 Solvency

An Altman-Z score of 2.78 indicates that CNXT is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score of CNXT (2.78) is better than 60.49% of its industry peers.
CNXT has a debt to FCF ratio of 6.05. This is a slightly negative value and a sign of low solvency as CNXT would need 6.05 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 6.05, CNXT is in line with its industry, outperforming 51.85% of the companies in the same industry.
A Debt/Equity ratio of 0.32 indicates that CNXT is not too dependend on debt financing.
The Debt to Equity ratio of CNXT (0.32) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF 6.05
Altman-Z 2.78
ROIC/WACC1.14
WACC7.14%
CNXT Yearly LT Debt VS Equity VS FCFCNXT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B 15B

2.3 Liquidity

A Current Ratio of 1.80 indicates that CNXT should not have too much problems paying its short term obligations.
CNXT has a Current ratio (1.80) which is comparable to the rest of the industry.
A Quick Ratio of 1.12 indicates that CNXT should not have too much problems paying its short term obligations.
CNXT has a Quick ratio (1.12) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.8
Quick Ratio 1.12
CNXT Yearly Current Assets VS Current LiabilitesCNXT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

More info and screens

4

3. Growth

3.1 Past

CNXT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -18.28%.
CNXT shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 1.64% yearly.
Looking at the last year, CNXT shows a decrease in Revenue. The Revenue has decreased by -3.62% in the last year.
Measured over the past years, CNXT shows a small growth in Revenue. The Revenue has been growing by 2.41% on average per year.
EPS 1Y (TTM)-18.28%
EPS 3Y0.78%
EPS 5Y1.64%
EPS Q2Q%-26.88%
Revenue 1Y (TTM)-3.62%
Revenue growth 3Y4.55%
Revenue growth 5Y2.41%
Sales Q2Q%-3.36%

3.2 Future

The Earnings Per Share is expected to grow by 15.63% on average over the next years. This is quite good.
The Revenue is expected to grow by 2.56% on average over the next years.
EPS Next Y21.13%
EPS Next 2Y18.35%
EPS Next 3Y15.63%
EPS Next 5YN/A
Revenue Next Year-1.8%
Revenue Next 2Y0.24%
Revenue Next 3Y1.32%
Revenue Next 5Y2.56%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
CNXT Yearly Revenue VS EstimatesCNXT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 10B 20B 30B
CNXT Yearly EPS VS EstimatesCNXT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3 4

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 17.26 indicates a rather expensive valuation of CNXT.
The rest of the industry has a similar Price/Earnings ratio as CNXT.
When comparing the Price/Earnings ratio of CNXT to the average of the S&P500 Index (27.86), we can say CNXT is valued slightly cheaper.
The Price/Forward Earnings ratio is 10.28, which indicates a very decent valuation of CNXT.
60.49% of the companies in the same industry are more expensive than CNXT, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.32, CNXT is valued rather cheaply.
Industry RankSector Rank
PE 17.26
Fwd PE 10.28
CNXT Price Earnings VS Forward Price EarningsCNXT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

61.73% of the companies in the same industry are more expensive than CNXT, based on the Enterprise Value to EBITDA ratio.
The rest of the industry has a similar Price/Free Cash Flow ratio as CNXT.
Industry RankSector Rank
P/FCF 21.48
EV/EBITDA 6.28
CNXT Per share dataCNXT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CNXT has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as CNXT's earnings are expected to grow with 15.63% in the coming years.
PEG (NY)0.82
PEG (5Y)10.51
EPS Next 2Y18.35%
EPS Next 3Y15.63%

More info and screens

6

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 4.52%, CNXT is a good candidate for dividend investing.
CNXT's Dividend Yield is a higher than the industry average which is at 4.02.
Compared to an average S&P500 Dividend Yield of 2.41, CNXT pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.52%

5.2 History

The dividend of CNXT is nicely growing with an annual growth rate of 7.84%!
CNXT has been paying a dividend for over 5 years, so it has already some track record.
Dividend Growth(5Y)7.84%
Div Incr Years0
Div Non Decr Years0
CNXT Yearly Dividends per shareCNXT Yearly Dividends per shareYearly Dividends per share 2017 2019 2020 2021 2024 1 2 3 4

5.3 Sustainability

62.40% of the earnings are spent on dividend by CNXT. This is not a sustainable payout ratio.
CNXT's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP62.4%
EPS Next 2Y18.35%
EPS Next 3Y15.63%
CNXT Yearly Income VS Free CF VS DividendCNXT Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B
CNXT Dividend Payout.CNXT Dividend Payout, showing the Payout Ratio.CNXT Dividend Payout.PayoutRetained Earnings

More info and screens

VANECK CHINEXT ETF

NYSEARCA:CNXT (10/3/2025, 8:04:03 PM)

44.3608

-0.22 (-0.49%)

Chartmill FA Rating
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobile Components
Earnings (Last)07-24 2025-07-24/amc
Earnings (Next)02-22 2026-02-22/amc
Inst Owners46.28%
Inst Owner Change-24.99%
Ins Owners0%
Ins Owner ChangeN/A
Market Cap31.31B
Analysts80.87
Price Target50.11 (12.96%)
Short Float %0.01%
Short Ratio2.99
Dividend
Industry RankSector Rank
Dividend Yield 4.52%
Yearly Dividend1.58
Dividend Growth(5Y)7.84%
DP62.4%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)24.17%
PT rev (3m)69.67%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-1.32%
EPS NY rev (3m)-10.51%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.16%
Revenue NY rev (3m)-2.61%
Valuation
Industry RankSector Rank
PE 17.26
Fwd PE 10.28
P/S 1
P/FCF 21.48
P/OCF 7.87
P/B 1.5
P/tB 2.04
EV/EBITDA 6.28
EPS(TTM)2.57
EY5.79%
EPS(NY)4.31
Fwd EY9.72%
FCF(TTM)2.07
FCFY4.66%
OCF(TTM)5.63
OCFY12.7%
SpS44.53
BVpS29.52
TBVpS21.73
PEG (NY)0.82
PEG (5Y)10.51
Profitability
Industry RankSector Rank
ROA 4.39%
ROE 8.81%
ROCE 10.41%
ROIC 8.17%
ROICexc 9.37%
ROICexgc 11.66%
OM 10.65%
PM (TTM) 5.84%
GM 27.6%
FCFM 4.64%
ROA(3y)5.45%
ROA(5y)4.73%
ROE(3y)10.95%
ROE(5y)10.02%
ROIC(3y)9.25%
ROIC(5y)8.5%
ROICexc(3y)10.37%
ROICexc(5y)9.81%
ROICexgc(3y)12.78%
ROICexgc(5y)12.13%
ROCE(3y)11.87%
ROCE(5y)10.97%
ROICexcg growth 3Y-1.65%
ROICexcg growth 5Y0.27%
ROICexc growth 3Y-2.16%
ROICexc growth 5Y0.21%
OM growth 3Y-2.46%
OM growth 5Y-1.24%
PM growth 3Y-3.58%
PM growth 5Y-0.79%
GM growth 3Y-0.99%
GM growth 5Y-0.59%
F-Score5
Asset Turnover0.75
Health
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF 6.05
Debt/EBITDA 1.17
Cap/Depr 107.96%
Cap/Sales 8.01%
Interest Coverage 9.96
Cash Conversion 70%
Profit Quality 79.44%
Current Ratio 1.8
Quick Ratio 1.12
Altman-Z 2.78
F-Score5
WACC7.14%
ROIC/WACC1.14
Cap/Depr(3y)113.8%
Cap/Depr(5y)101.88%
Cap/Sales(3y)7.8%
Cap/Sales(5y)7.31%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-18.28%
EPS 3Y0.78%
EPS 5Y1.64%
EPS Q2Q%-26.88%
EPS Next Y21.13%
EPS Next 2Y18.35%
EPS Next 3Y15.63%
EPS Next 5YN/A
Revenue 1Y (TTM)-3.62%
Revenue growth 3Y4.55%
Revenue growth 5Y2.41%
Sales Q2Q%-3.36%
Revenue Next Year-1.8%
Revenue Next 2Y0.24%
Revenue Next 3Y1.32%
Revenue Next 5Y2.56%
EBIT growth 1Y-17.5%
EBIT growth 3Y1.98%
EBIT growth 5Y1.14%
EBIT Next Year59.12%
EBIT Next 3Y22.78%
EBIT Next 5Y17.51%
FCF growth 1Y-20.46%
FCF growth 3Y21.5%
FCF growth 5Y7.22%
OCF growth 1Y-10.1%
OCF growth 3Y14.27%
OCF growth 5Y5.48%